Small molecule inhibitors of Candida albicans biofilm formation

描述（由申请人提供）：念珠菌病目前是美国和世界范围内第四大最常见的医院感染。白色念珠菌仍然是念珠菌病最常见的病原体。不幸的是，这些感染与不可接受的高发病率和死亡率有关。念珠菌病的多种表现与不同类型表面上的生物膜形成有关。生物膜的形成带来了重要的后果，因为生物膜中的固着细胞显示出与它们的异源对应物显著不同的表型性状，例如对抗真菌剂的抗性增加和免受宿主防御的保护。一旦建立，生物膜就有可能通过提供一个安全的储库来启动或延长感染，生物体可以从该储库侵入局部组织、播种新的感染部位或抵抗根除努力。净效应是念珠菌生物膜对这些患者的健康产生不利影响，频率和严重程度增加，经济后遗症飙升。因此，提出的研究的主要目标是设计新的策略，以防止C。白色念珠菌生物膜形成。为此，我们将：i）使用基于表型的方法，该方法基于高通量筛选抑制C.白色念珠菌生物膜形成，和ii）表征在初始筛选期间鉴定为“命中物”和“先导物”的所选生物活性分子的生物膜抑制作用。这些分析利用了本实验室开发的用于念珠菌生物膜形成的简单、快速、稳健、准确和高度可重复的基于微量滴定的模型，非常适合自动化和高通量应用。基于小分子的方法提供了强有力的手段来解决实验上具有挑战性和复杂的生物学现象，如生物膜形成，同时为药物开发确定新的潜在靶点。生物膜的形成对人类健康具有严重的后果。这项研究背后的主要思想是，通过消除C。因此，通过将白色念珠菌转化成生物膜，可以实现发病率、死亡率和延长住院时间的大幅降低，同时降低医疗保健成本。

DESCRIPTION (provided by applicant): Candidiasis represents now the fourth most frequent nosocomial infection in the US and worldwide and C. albicans remains the most frequent causative agent of candidiasis. Unfortunately these infections are associated with unacceptably high morbidity and mortality rates. A variety of manifestations of candidiasis are associated with biofilm formation on the surface of different types of surfaces. Biofilm formation carries important consequences since sessile cells in biofilms display phenotypic traits that are dramatically different from their planktonic counterparts, such as increased resistance to antifungal agents and protection from host defenses. Once established, biofilms have the potential to initiate or prolong infections by providing a safe reservoir from which organisms can invade local tissue, seed new infection sites, or resist eradication efforts. The net effect is that Candida biofilms adversely impact the health of these patients, with increasing frequency and severity, and with soaring economic sequelae. Therefore, the main objective of the proposed studies is to devise novel strategies to prevent C. albicans biofilm formation. To this end we will: i) use a phenotype-based approach based on the high throughput screening for small molecule compounds which inhibit C. albicans biofilm formation, and ii) characterize the biofilm-inhibitory effects of selected bioactive molecules identified as "hits" and "leads" during the initial screens. These assays take advantage of a simple, rapid, robust, accurate and highly reproducible microtiter-based model for the formation of Candida biofilms developed in this laboratory that is ideally suited for automation and high throughput applications. Small-molecule-based approaches provide powerful means to address experimentally challenging and complex biological phenomena, such as biofilm formation, while simultaneously identifying new potential targets for drug development. to public health: Biofilm formation has severe consequences for human health. The main idea behind this study is that by eliminating the ability of C. albicans to form biofilms, a substantial reduction in morbidity, mortality and extended hospital stay can be achieved while simultaneously reducing healthcare costs.